Strategic Plan

Overview

In October 2010, the HOPA Board of Directors, key stakeholders and staff met to review and update its strategic direction for the future. The resulting strategic plan builds on HOPA’s successes to date and stretches the association into the future. The desired outcome of the planning process is to create clarity and focus on how HOPA should invest its valuable and limited resources in meeting the future needs of its members and other stakeholders it serves. 

• A set of factors in the long-range horizon (10+ years into the future) to guide decision-making including a core purpose, core values, Big Audacious Goal (BHAG) and a vivid description of future success;
• Focused goal areas that identify where the association will direct its energy in the next five years. The goal areas focus on outcomes beneficial to the association and its members.
• A set of objectives in each goal area setting measurable direction for the association to head in to achieve its goals.

HOPA’s leadership views strategic thinking and planning as an ongoing process within the organization. This is not a “strategic planning project” that is completed. Adoption of a plan is an affirmation of the general intent and direction articulated by the vision, goals, and objectives. Progress toward achieving the plan’s objectives will be assessed annually and the plan will be updated based on achievement and changes in the needs of the stakeholders served.

Envisioned Future

Big Audacious Goal (BHAG):  
All individuals affected by cancer have a hematology/oncology pharmacist as an integral member of their care team.

Vivid Description of a Desired Future:
HOPA is recognized as the leading and most influential global organization for hematology/oncology pharmacists and their practice. Healthcare professionals involved in the care of individuals affected by cancer understand the important contribution oncology pharmacy practitioners make in cancer prevention, treatment, and surveillance of patients as a result of HOPA’s commitment to and advocacy for the profession. Other organizations look to HOPA for expertise on and support for legislation and regulations affecting the prevention and treatment of cancer.  HOPA works on behalf of the profession to ensure patients have open access to drug therapies in order to optimize care.

HOPA sets the standards for hematology/oncology pharmacy and is considered the premier organization for education and training in the field.  Pharmacists, pharmacy technicians, nurses, physician assistants and other healthcare professionals take advantage of HOPA’s training opportunities and other resources.  Cancer patients and their caregivers utilize HOPA as a source of information on anticancer drug therapies and related treatments.  Oncology pharmacists utilize HOPA as their primary community for support, education, and information.  HOPA leads the discussion on student and resident education and training in hematology/oncology pharmacy at the college and hospital level. 

HOPA members are engaged and committed to the association and its strategic direction.  HOPA members are also actively engaged in leadership within their work environments and as advocates for hematology/oncology pharmacy.  Collaborations with pharmaceutical industry, other cancer-related professional organizations, and patient support groups are sought by HOPA and its members in order to ensure the voice of the profession is included. 
Research and evidence-based approaches drive the practice of hematology/oncology pharmacists and the direction of HOPA.  HOPA supports the hematology/oncology pharmacist researcher in interdisciplinary endeavors to advance care and practice. 

As a result, cancer patients and their caregivers have greater knowledge of and access to drug therapies.

10+ Year Planning Horizon: Core Ideology and Envisioned Future

Core Ideology

Core Purpose: To support pharmacy practitioners and promote and advance Hematology/Oncology Pharmacy to optimize the care of individuals affected by cancer.

Core Organizational Values:

• Leadership
• Collaboration
• Integrity
• Responsive
• Innovation
• Caring

Five-Year Planning Horizon: Goals and Objectives

Priority Key:
(H) = Must begin objective in next fiscal year
(M) = May begin objective, if resources permit, in next fiscal year
(L) = Begin objective in subsequent fiscal year

Goal Area: Education
Goal Statement: HOPA is recognized and utilized as the expert in providing hematology/oncology education to support pharmacists involved in the care of cancer patients.

 Audience Segments:

• Full-time h/o pharmacists
• BCOPs
• Pharmacists
• Trainees

Objectives:

• Increase the utilization of HOPA educational initiatives through marketing to targeted audiences. (H)
• Increase the breadth, quality, and quantity of HOPA’s educational initiatives.  (H)
• Increase HOPA’s involvement in BCOP preparation and recertification. (M)

Goal Area: Hematology/Oncology Pharmacy Practice Standards
Goal Statement: HOPA is the source for practice standards to support roles and responsibilities of hematology/oncology pharmacists across the cancer continuum.

Objectives:

• Increase understanding of the hematology/oncology pharmacist scope of practice across the cancer care continuum.  (H)
• Enhance practice through the use of evidence-based standards. (M/L)

Goal Area:  Advocacy
Goal Statement:  HOPA and its members are recognized as important partners by the pharmacy and cancer communities and are able to influence decisions affecting the care of cancer patients.

Objectives:

• Increase HOPA’s capacity to support and maintain a robust health policy agenda and program. (H)
• Increase members engagement in HOPA’s advocacy initiatives (develop a critical mass of members who are actively engaged in advocacy) (M/L)
• Establish HOPA as a recognized stakeholder on oncology pharmacy practice issues such as quality, access, safety and economics (cost). (L)